Anti-MGMT antibody (1-100) [PTR2300] (STJA0006253)

SKU:
STJA0006253

Current Stock:
Host: Mouse
Applications: WB/ELISA
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Mouse monoclonal antibody anti-Methylated-DNA--protein-cysteine methyltransferase (1-100) is suitable for use in Western Blot and ELISA research applications.
Clonality: Monoclonal
Clone ID: PTR2300
Conjugation: Unconjugated
Isotype: IgG2bk
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: MGMT
Gene ID: 4255
Uniprot ID: MGMT_HUMAN
Immunogen Region: 1-100
Specificity: This antibody detects endogenous levels of MGMT at Human, Predict react with Mouse;Rat
Immunogen: Synthesized peptide derived from human MGMT AA range: 1-100
Function Involved in the cellular defense against the biological effects of O6-methylguanine (O6-MeG) and O4-methylthymine (O4-MeT) in DNA. Repairs the methylated nucleobase in DNA by stoichiometrically transferring the methyl group to a cysteine residue in the enzyme. This is a suicide reaction: the enzyme is irreversibly inactivated.
Protein Name Methylated-Dna--Protein-Cysteine Methyltransferase
6-O-Methylguanine-Dna Methyltransferase
Mgmt
O-6-Methylguanine-Dna-Alkyltransferase
Database Links Reactome: R-HSA-5657655
Cellular Localisation Nucleus
Alternative Antibody Names Anti-Methylated-Dna--Protein-Cysteine Methyltransferase antibody
Anti-6-O-Methylguanine-Dna Methyltransferase antibody
Anti-Mgmt antibody
Anti-O-6-Methylguanine-Dna-Alkyltransferase antibody
Anti-MGMT antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance